Autor: "Crocchiolo Roberto" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Human Leucocyte Antigen System and Selection of Unrelated Hematopoietic Stem Cell Donors: Impact of Patient-Donor (Mis)matching and New Challenges with the Current Technologies.
Autorzy:: Crocchiolo R; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza dell'Ospedale Maggiore, 3, 20162 Milano, Italy.
Rombolà G; Laboratory of Immunogenetics and Transplant Immunology, Azienda Ospedaliero-Universitaria Careggi, 50134 Firenze, Italy.; Pokaż więcej
Źródło:: Journal of clinical medicine [J Clin Med] 2023 Jan 13; Vol. 12 (2). Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:: Journal Article; Review

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Polymorphism of the HLA system and weak antibody response to BNT162b2 mRNA vaccine.
Autorzy:: Crocchiolo R; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Gallina AM; Italian Bone Marrow Donor Registry, E. O. Ospedali Galliera, Genoa, Italy.
Pani A; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Campisi D; Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cento V; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Sacchi N; Italian Bone Marrow Donor Registry, E. O. Ospedali Galliera, Genoa, Italy.
Miotti V; Laboratory of Immunogenetics, Santa Maria della Misericordia University Hospital, Udine, Italy.
Gagliardi OM; Postgraduate School of Clinical Pharmacology and Toxicology, Università degli Studi di Milano, Milan, Italy.
D'Amico F; Department of Infectious Diseases Unit, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Vismara C; Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cornacchini G; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Lando G; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Cuppari I; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Scaglione F; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Chemical-Clinical and Microbiological Analyses, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Rossini S; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Pokaż więcej
Źródło:: HLA [HLA] 2022 Mar; Vol. 99 (3), pp. 183-191. Date of Electronic Publication: 2022 Jan 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibody Formation*
COVID-19*/prevention & control
HLA-DRB1 Chains*/genetics
BNT162 Vaccine/*immunology
Alleles ; Antibodies, Viral/immunology ; Gene Frequency ; Haplotypes ; Humans ; SARS-CoV-2 ; Vaccines, Synthetic/immunology ; mRNA Vaccines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Use of DPB1 T-cell epitope algorithm among italian transplant centers: A survey on behalf of Associazione Italiana di Immunogenetica e Biologia dei Trapianti.
Autorzy:: Crocchiolo R; Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Mele L; Laboratorio HLA e processazione cellule staminali ematopoietiche, Azienda Ospedaliera SS Antonio e Biagio e C Arrigo, Alessandria, Italy; Treasurer, Associazione Italiana di Immunogenetica e Biologia dei Trapianti, AIBT, Alessandria, Italy.
Testi M; Secretary, Associazione Italiana di Immunogenetica e Biologia dei Trapianti, AIBT, Bologna, Italy.
Scollo Chiara M; Ematologia, Ospedale San Gerardo ASST, Monza, Italy.
Murgia B; SC laboratorio di istocompatibilità, EO Ospedali Galliera, Genoa, Italy.
Rossi A; UOSD Immunogenetica e Manipolazione cellule staminali emopoietiche, Ospedale ''Guglielmo da Saliceto'', Piacenza, Italy.
Vecchiato C; Transfusion Service, San Maurizio Regional Hospital, Bolzano, Italy.
Grammatico P; UOC Laboratorio di Genetica Medica, Ospedale San Camillo, Rome, Italy.
Mininni D; Tissue Typing and Immunology of Transplants Unit, Department of Diagnostic Pathology, University of Bari, Bari, Italy.
Longhi E; Laboratory of Transplant Immunology, IRCCS Ca ' Granda Foundation Maggiore Policlinico Hospital Milan, Milan, Italy.
Manfroi S; Immunohaematology and Transfusion Medicine Service, S. Orsola-Malpighi Polyclinic, Bologna, Italy.
Giuliodori S; Immunogenetica dei trapianti - AOU, Parma, Italy.
Castellani L; UOC immunoematologia e medicina trasfusionale, Laboratorio immunogenetica - ASST Papa Giovanni XXIII, Bergamo, Italy.
Carella G; Laboratorio di Istocompatibilità, ''Vittorio Mero'' Servizio di Immunoematologia e Medicina Trasfusionale, ASST Spedali Civili, Brescia, Italy.
Lai S; SC Genetica Medica Cagliari - ATS Sardegna, Cagliari, Italy.
Azzaro Maria P; Laboratorio di istocompatibilità, Centro Donatori di midollo Osseo (CD-CT02) dell'UOC di Ematologia con trapianto di Midollo Ossero - AOU Policlinico San Marco, Catania, Italy.
Mazzi B; Immunogenetics laboratory, HLA & Chimerism - Dept. of ImmunoHematology & Blood Transfusion, IRCCS Ospedale San Raffaele, Milan, Italy.
Perotti L; Servizio di Immunoematologia e Trasfusionale, ASO Santa Croce e Carle, Cuneo, Italy.
Penta R; Laboratorio di istoconpatibilità, UOSD Criopreservazione e BaSCO, PO Pausilipon - AORN Santobono-Pausilipon, Naples, Italy.
Lombardo C; Laboratorio di Tipizzazione HLA, Servizio Di Immunoematologia e Medicina Trasfusionale, Fondazione IRCSS Istituto Tumori, Milan, Italy.
Tognellini R; Laboratorio di immunogenetica e biologia dei trapianti, Servizio Immunoematologia e trasfusionale, Azienda Ospedaliera Perugia, Perugia, Italy.
Andreani M; Transplantation Immunogenetics Laboratory, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Albergoni Maria P; Department of Transfusion Medicine, University Hospital of Padova, Padua, Italy.
Nesci S; Settore di Immunogenetica e Biologia dei Trapianti, S.S.D. Diagnostica ad alta complessità - Dipartimento di Diagnostica Clinica, Azienda Ospedali Riuniti Marche Nord-, Pesaro, Italy.
Cappuzzo V; Laboratorio Regionale di Tipizzazione Tessutale ed Immunologia dei Trapianti, U.O.C. Medicina Trasfusionale e dei Trapianti - P.O. Cervello - A.O.R. Villa Sofia-Cervello, Palermo, Italy.
Chiusolo P; Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.
Garino E; SC Immunogenetica e Biologia dei Trapianti, A.O.U. Città della Salute e della Scienza di Torino, Pavia, Italy.
Cappucci G; IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy.
Ceschini N; Laboratorio di Tipizzazione Tissutale HLA, S.I.T., Ospedale Santa Chiara, Trento, Italy.
Bevilacqua E; Laboratorio di Tipizzazione tissutale, Dipartimento di Medicina Trasfusionale, Azienda Sanitaria Universitaria Giuliano Isontina - ASUGI, Trieste, Italy.
Guizzardi E; Service of Transfusion Medicine, AOUI, Verona, Italy.
Tagliaferri Cinzia M; UOS Immunogenetica HLA, AULSS 8 Berica - Ospedale San Bortolo, Vicenza, Italy.
Piazza A; Associazione Italiana di Immunogenetica e Biologia dei Trapianti, AIBT, Bologna, Italy.
Carcassi C; Medical Genetics, Department of Medical Sciences and Public Health, University of Cagliari, Associazione Italiana di Immunogenetica e Biologia dei Trapianti, AIBT, Cagliari, Italy.
Miotti V; Laboratory of Immunogenetics, Santa Maria della Misericordia University Hospital, Associazione Italiana di Immunogenetica e Biologia dei Trapianti, AIBT, Udine, Italy.; Pokaż więcej
Źródło:: HLA [HLA] 2021 Aug; Vol. 98 (2), pp. 114-121. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji:: Journal Article
MeSH Terms:: Epitopes, T-Lymphocyte*
HLA-DP beta-Chains*
Hematopoietic Stem Cell Transplantation*
Algorithms ; Alleles ; Histocompatibility Testing ; Humans ; Italy ; Surveys and Questionnaires ; Unrelated Donors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Correction to: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial.
Autorzy:: Crocchiolo R; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy. roberto.crocchiolo@ospedaleniguarda.it.
Cesana C; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Girgenti D; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Bertani G; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Barba C; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Liga G; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Ferri U; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Crucitti L; ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Grillo G; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Rossini S; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Cairoli R; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.; Pokaż więcej
Źródło:: Experimental hematology & oncology [Exp Hematol Oncol] 2021 Mar 17; Vol. 10 (1), pp. 22. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji:: Published Erratum

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial.
Autorzy:: Crocchiolo R; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy. roberto.crocchiolo@ospedaleniguarda.it.
Cesana C; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Girgenti D; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Bertani G; Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Barba C; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Liga G; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Ferri U; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Crucitti L; Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Grillo G; Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Rossini S; Servizio Di Immunoematologia E Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Piazza Dell'Ospedale Maggiore, 3, 20162, Milano, Italy.
Cairoli R; Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.; Pokaż więcej
Źródło:: Experimental hematology & oncology [Exp Hematol Oncol] 2021 Feb 16; Vol. 10 (1), pp. 14. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji:: Letter

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Autorzy:: Sarina B; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Mariotti J; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Bramanti S; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Morabito L; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Crocchiolo R; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Rimondo A; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Tordato F; Infectious Diseases Unit, Hospital Health Direction, IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
Pocaterra D; Infectious Diseases Unit, Hospital Health Direction, IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
Casari E; Infectious Diseases Unit, Hospital Health Direction, IRCCS Istituto Clinico Humanitas, Rozzano, Italy.
De Philippis C; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Carlo-Stella C; Hematology Department, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Santoro A; Hematology Department, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.
Castagna L; Bone Marrow Unit, Humanitas Cancer Center, Istituto Clinico Humanitas, Rozzano, Italy.; Pokaż więcej
Źródło:: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2018 Aug; Vol. 20 (4), pp. e12906. Date of Electronic Publication: 2018 May 16.
Typ publikacji:: Journal Article
MeSH Terms:: Antibiotic Prophylaxis/*methods
Antifungal Agents/*administration & dosage
Fluconazole/*administration & dosage
Hematopoietic Stem Cell Transplantation/*adverse effects
Invasive Fungal Infections/*prevention & control
Adolescent ; Adult ; Aged ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Graft vs Host Disease/epidemiology ; Graft vs Host Disease/immunology ; Graft vs Host Disease/prevention & control ; HLA Antigens/immunology ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Incidence ; Invasive Fungal Infections/epidemiology ; Invasive Fungal Infections/microbiology ; Living Donors ; Lymphoma/immunology ; Lymphoma/mortality ; Lymphoma/surgery ; Male ; Middle Aged ; Retrospective Studies ; Siblings ; Survival Rate ; Transplantation Conditioning/adverse effects ; Transplantation Conditioning/methods ; Transplantation, Homologous/adverse effects ; Transplantation, Homologous/methods ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.
Autorzy:: Mineri R; Molecular Biology Section, Clinical Investigation Laboratory, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Mariotti J; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Sarina B; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Morabito L; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Crocchiolo R; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Bramanti S; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Sarno T; Molecular Biology Section, Clinical Investigation Laboratory, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Tordato F; Infectious Disease Unit, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Carlo-Stella C; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.
Santoro A; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.; Humanitas University, Via Alessandro Manzoni 113, 20089 Rozzano (Mi), Italy.
Castagna L; Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center, Via Manzoni 56, Rozzano 20089, Italy.; Pokaż więcej
Źródło:: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2018 Feb 15; Vol. 10 (1), pp. e2018013. Date of Electronic Publication: 2018 Feb 15 (Print Publication: 2018).
Typ publikacji:: Case Reports

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia.
Autorzy:: Wanquet A; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;
Crocchiolo R; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Furst S; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Granata A; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Faucher C; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Devillier R; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Harbi S; c Centre de Thérapie Cellulaire , Institut Paoli-Calmettes , Marseille , France.
Lemarie C; c Centre de Thérapie Cellulaire , Institut Paoli-Calmettes , Marseille , France.
Calmels B; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;
Vey N; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;
Weiller PJ; c Centre de Thérapie Cellulaire , Institut Paoli-Calmettes , Marseille , France.
Chabannon C; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Castagna L; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
Blaise D; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;
El-Cheikh J; a Département d'Onco-Hématologie , Institut Paoli-Calmettes , Marseille , France ;; b Unité de Transplantation et de Thérapie Cellulaire (U2T) , Institut Paoli-Calmettes , Marseille , France ;; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2016 Oct; Vol. 57 (10), pp. 2315-20. Date of Electronic Publication: 2016 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Transplantation Conditioning*/adverse effects
Transplantation Conditioning*/methods
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Myeloid, Acute/*therapy
Myelodysplastic Syndromes/*therapy
Adult ; Aged ; Antilymphocyte Serum/administration & dosage ; Busulfan/administration & dosage ; Comorbidity ; Female ; Graft Rejection ; Graft Survival ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Humans ; Kaplan-Meier Estimate ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/mortality ; Retrospective Studies ; Transplantation, Homologous ; Treatment Outcome ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Autorzy:: Saillard C; Hematology Department, Institut Paoli-Calmettes , Marseille , France.
Crocchiolo R
Furst S
El-Cheikh J
Castagna L
Signori A
Oudin C
Faucher C
Lemarie C
Chabannon C
Granata A
Blaise D; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2014 May; Vol. 55 (5), pp. 1106-12. Date of Electronic Publication: 2014 Feb 04.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Transplantation Conditioning*
Graft vs Host Disease/*diagnosis
Graft vs Host Disease/*etiology
Adolescent ; Adult ; Aged ; Antilymphocyte Serum/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Busulfan/administration & dosage ; Chemoprevention ; Chronic Disease ; Disease Progression ; Graft vs Host Disease/drug therapy ; Graft vs Host Disease/mortality ; Graft vs Host Disease/prevention & control ; Hematologic Neoplasms/complications ; Hematologic Neoplasms/diagnosis ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; Humans ; Middle Aged ; Recurrence ; Severity of Illness Index ; Transplantation, Homologous ; Treatment Outcome ; Vidarabine/administration & dosage ; Vidarabine/analogs & derivatives ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia.
Autorzy:: Devillier R; Hematology Department, Institut Paoli-Calmettes, Marseille, France.
Crocchiolo R
Etienne A
Prebet T
Charbonnier A
Fürst S
El-Cheikh J
D'Incan E
Rey J
Faucher C
Blaise D
Vey N; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2013 Jun; Vol. 54 (6), pp. 1228-34. Date of Electronic Publication: 2012 Nov 19.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute/*therapy
Adolescent ; Adult ; Aged ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Middle Aged ; Prognosis ; Recurrence ; Salvage Therapy ; Transplantation, Homologous ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Impact of pretransplant donor and recipient cytomegalovirus serostatus on outcome for multiple myeloma patients undergoing reduced intensity conditioning allogeneic stem cell transplantation.
Autorzy:: El-Cheikh J; Unité de Transplantation et de Thérapie Cellulaire (U2T), Institut Paoli-Calmettes, Marseille, France. ; Département d'Onco-Hématologie, Institut Paoli-Calmettes, Marseille, France.
Devillier R
Crocchiolo R
Fürst S
Calmels B
Faucher C
Stoppa AM
Granata A
Castagna L
Ladaique P
Lemarie C
Bouabdallah R
Zandotti C
Merlin M
Berger P
Chabannon C
Blaise D; Pokaż więcej
Źródło:: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2013 Apr 10; Vol. 5 (1), pp. e2013026. Date of Electronic Publication: 2013 Apr 10 (Print Publication: 2013).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
Autorzy:: Crocchiolo R
Chabannon C
El-Cheikh J
Esterni B
Lemarié C
Fürst S
Castagna L
Bouabdallah R
Ladaique P
Coso D
Schiano JM
Stoppa AM
Rey J
Ivanov V
Aurran T
Faucher C
Blaise D
Calmels B; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2013 Feb; Vol. 54 (2), pp. 417-20. Date of Electronic Publication: 2012 Jul 09.
Typ publikacji:: Letter
MeSH Terms:: Hematopoietic Stem Cell Mobilization*
Lymphoma/*therapy
Multiple Myeloma/*therapy
Hematopoietic Stem Cell Transplantation ; Humans ; Lymphoma/mortality ; Multiple Myeloma/mortality ; Transplantation, Autologous ; Transplantation, Homologous ; Treatment Outcome

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Successful treatment of post-transplant Epstein-Barr virus-related meningoencephalitis by intravenous rituximab monotherapy.
Autorzy:: Crocchiolo R
Ciccolini J
El-Cheikh J
Fürst S
Castagna L
Granata A
Oudin C
Harbi S
Devillier R
Legall S
Ternant D
Paintaud G
Lacarelle B
Blaise D; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2012 Oct; Vol. 53 (10), pp. 2063-5. Date of Electronic Publication: 2012 Apr 19.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Antibodies, Monoclonal, Murine-Derived/*therapeutic use
Epstein-Barr Virus Infections/*drug therapy
Immunologic Factors/*therapeutic use
Meningoencephalitis/*drug therapy
Bilirubin/blood ; Epstein-Barr Virus Infections/etiology ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Herpesvirus 4, Human/genetics ; Humans ; Meningoencephalitis/etiology ; Middle Aged ; Rituximab ; Transplantation, Homologous ; Treatment Outcome ; Viral Load

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?
Autorzy:: El-Cheikh J
Crocchiolo R
Boher JM
Fürst S
Stoppa AM
Faucher C
Castagna L
Granata A
Oudin C
De Colella JM
Coso D
Bouabdallah R
Mohty M
Blaise D; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2012 Aug; Vol. 53 (8), pp. 1630-2. Date of Electronic Publication: 2012 Feb 13.
Typ publikacji:: Letter
MeSH Terms:: Multiple Myeloma/*therapy
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Female ; Humans ; Male ; Medical Oncology/methods ; Melphalan/therapeutic use ; Middle Aged ; Multiple Myeloma/mortality ; Risk ; Stem Cell Transplantation/methods ; Transplantation Conditioning/methods ; Transplantation, Homologous ; Treatment Outcome

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma.
Autorzy:: El-Cheikh J; Unité de Transplantation et de Thérapie Cellulaire (U2T), Institut Paoli-Calmettes, Marseille, France. />Crocchiolo R
Boher JM
Furst S
Stoppa AM
Ladaique P
Faucher C
Calmels B
Castagna L
Lemarie C
De Colella JM
Coso D
Bouabdallah R
Chabannon C
Blaise D; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2012 Jun; Vol. 88 (6), pp. 497-503. Date of Electronic Publication: 2012 Apr 04.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/mortality
Multiple Myeloma/*therapy
Adult ; Aged ; Disease-Free Survival ; Female ; Graft vs Host Disease/etiology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Siblings ; Tissue Donors ; Transplantation Conditioning ; Transplantation, Autologous ; Transplantation, Homologous

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.
Autorzy:: El-Cheikh J; Unité de Transplantation et de Thérapie Cellulaire (U2T), Institut Paoli-Calmettes, Marseille, France.
Fürst S
Casalonga F
Crocchiolo R
Castagna L
Granata A
Oudin C
Faucher C
Berger P
Sarran A
Blaise D; Pokaż więcej
Źródło:: Mediterranean journal of hematology and infectious diseases [Mediterr J Hematol Infect Dis] 2012; Vol. 4 (1), pp. e2012043. Date of Electronic Publication: 2012 Jun 20.
Typ publikacji:: Case Reports